Theravance Biopharma, Inc. (TBPH)
13.57
-0.01
(-0.07%)
USD |
NASDAQ |
Mar 06, 16:00
13.56
-0.01
(-0.07%)
After-Hours: 20:00
Theravance Biopharma Free Cash Flow : 243.48M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Integer Holdings Corp. | 105.12M |
| QuidelOrtho Corp. | -83.00M |
| Corcept Therapeutics, Inc. | 141.78M |
| Nektar Therapeutics | -190.35M |
| Innoviva, Inc. | 195.80M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.508M |
| Cash from Investing (Quarterly) | -100.25M |
| Cash from Financing (Quarterly) | -0.40M |
| Free Cash Flow Per Share (Quarterly) | -0.1254 |
| Free Cash Flow to Equity (Quarterly) | -4.646M |
| Free Cash Flow to Firm (Quarterly) | -7.225M |
| Free Cash Flow Yield | 35.59% |